Maccura Biotechnology Co.Ltd(300463) independent director
Independent opinions on matters related to the first meeting of the Fifth Board of directors
In accordance with relevant laws, regulations and normative documents such as the rules for independent directors of listed companies, the standards for the governance of listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for the standardized operation of companies listed on gem, as well as the articles of association and the working system of independent directors of the company, As an independent director of the company, on the basis of carefully reading the relevant meeting materials of the first meeting of the Fifth Board of directors and listening to the reports of relevant personnel, based on the position of independent judgment and the principle of objectivity, impartiality and prudence, we express the following independent opinions on the matters involved in the relevant proposals considered by the board of directors: I. independent opinions on the appointment of senior managers of the company
1. The nomination and appointment procedures of the company’s senior managers comply with the relevant provisions of the company law, the Listing Rules of Shenzhen Stock Exchange on the gem, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for the standardized operation of listed companies on the gem and other normative documents and the articles of association, and the procedures are legal and effective.
2. After reviewing the resumes of relevant personnel, the senior managers of the company employed this time have met the employment conditions specified in relevant laws and regulations and the articles of association, and no company law, Shenzhen Stock Exchange GEM Listing Rules No. 2 self regulatory guidelines for listed companies of Shenzhen Stock Exchange – Guidelines for the standardized operation of companies listed on the gem and other normative documents stipulate that they are not allowed to serve as senior managers of the company, and it is not found that they are prohibited from entering the securities market by the CSRC; Not publicly recognized by the stock exchange as unfit to serve as directors, supervisors and senior managers of listed companies; Not subject to administrative punishment by the CSRC or public condemnation or criticism by the stock exchange; Not being placed on file for investigation by judicial organs for suspected crimes or being placed on file for investigation by CSRC for suspected violations of laws and regulations; It does not belong to the dishonest executee. And have the qualifications of senior managers of listed companies.
3. After understanding the educational background and work experience of relevant personnel, we believe that the senior managers employed this time have the professional ethics, professional knowledge and management ability required to perform their corresponding duties and are competent for the corresponding posts.
4. The appointment of senior managers will not result in the total number of directors who concurrently serve as senior managers of the company and staff representatives in the board of directors of the company exceeding one-half of the total number of directors of the company.
5. Ms. Shi Wei has obtained the qualification certificate of secretary of the board of directors issued by Shenzhen Stock Exchange and has the necessary professional knowledge and ability to perform the duties of secretary of the board of directors.
We unanimously agree that the company intends to reappoint Mr. Wu Mingjian as the general manager of the company; Mr. Xu Shengguo was reappointed as the director of market operation, Mr. long TengXiang as the director of R & D (Reagent), Mr. Wang Weijia as the director of R & D (instrument), Ms. Yang Hui as the director of production (Reagent), Mr. Wang Zhen as the director of production (instrument), Mr. Li Bo as the director of business, Ms. Yin Shan as the chief financial officer and Ms. Yu Ping as the chief administrative officer; Renew Ms. Shi Wei as director of strategic investment and Secretary of the board of directors. The term of office of the above-mentioned senior managers starts from the date of deliberation and approval of the current board of directors to the date of expiration of the term of office of the Fifth Board of directors.
The convening and voting procedures of this meeting comply with the provisions of laws and regulations, normative documents and the articles of association, and the resolutions formed at the meeting are legal and effective.
(no text below this page)
(there is no text on this page, which is the signature page of independent opinions on matters related to the first meeting of the Maccura Biotechnology Co.Ltd(300463) Fifth Board of directors) independent directors:
Fu daiguo, Liang Kaicheng, Liao Zhenzhong
Maccura Biotechnology Co.Ltd(300463)
January 17, 2002
